RAC1 and non-small cell lung carcinoma: Furthermore, in cells treated with the RAC1 inhibitor, expression of nuclear-localized TIAM1 was no longer able to reverse the decrease in migration observed with TIAM1 knockdown (Fig. 3C), suggesting that nuclear TIAM1 requires RAC1 activity to promote NSCLC cell migration.